In my role as Head of Infectious Diseases & Vaccines Innovative Medicines unit (iMED) at MedImmune, I lead a cross-functional team dedicated to the therapeutic area strategy, prioritization and advancement of the company’s infectious disease and vaccine portfolio. I joined MedImmune in 2010 as Senior Vice President of R&D and Head of the Infectious Diseases & Vaccines iMED.